{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["glioblastoma multiform", "invasion", "matrix metalloproteinase", "migration", "urolithin B"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36310375", "DateCompleted": {"Year": "2023", "Month": "04", "Day": "14"}, "DateRevised": {"Year": "2023", "Month": "04", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "10", "Day": "30"}], "Language": ["eng"], "ELocationID": ["10.1002/biof.1915"], "Journal": {"ISSN": "1872-8081", "JournalIssue": {"Volume": "49", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Mar"}}, "Title": "BioFactors (Oxford, England)", "ISOAbbreviation": "Biofactors"}, "ArticleTitle": "Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B\u00a0through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity.", "Pagination": {"StartPage": "379", "EndPage": "389", "MedlinePgn": "379-389"}, "Abstract": {"AbstractText": ["One kind of brain cancer with a dismal prognosis is called glioblastoma multiforme (GBM) due to its high growth rate and widespread tumor cell invasion into various areas of the brain. To improve therapeutic approaches, the objective of this research investigates the cytotoxic, anti-metastatic, and apoptotic effect of urolithin-B (UB) as a bioactive metabolite of ellagitannins (ETs) on GBM U87 cells. The malignant GBM cell line (U87) was examined for apoptosis rate, cell cycle analysis, cell viability, mRNA expressions of several apoptotic and metastasis-associated genes, production of reactive oxygen species (ROS), MMP-2, and MMP-9 activity and protein expression, and migration ability. The findings revealed that UB decreased U87 GBM viability in a dose-dependent manner and NIH/3T3 normal cells with the IC<sub>50</sub> value of 30 and 55\u00a0\u03bcM after 24\u2009h, respectively. UB also induces necrosis and G0/G1 cell cycle arrest in U87 cells. UB also increases ROS production and caused down-regulation of Bcl2 and up-regulation of Bax apoptotic genes. Additionally, treatment of UB reduced the migration of U87 cells. The protein levels, mRNA expression, and the MMP-2 and MMP-9 enzyme activities also decreased concentration-dependently. So, due to the non-toxic nature of UB and its ability to induce apoptosis and reduce the U87 GBM cell invasion and migration, after more research, it can be regarded as a promising new anti-GBM compound."], "CopyrightInformation": "\u00a9 2022 International Union of Biochemistry and Molecular Biology."}, "AuthorList": [{"Identifier": ["0000-0002-3086-2678"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran."}], "LastName": "Eidizade", "ForeName": "Fateme", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran."}, {"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}, {"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Soukhtanloo", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran."}, {"Identifier": [], "Affiliation": "New Materials Technology and Processing Research Center, Department of Chemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran."}], "LastName": "Zhiani", "ForeName": "Rahele", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Neyshabur Branch, Islamic Azad University, Neyshabur, Iran."}], "LastName": "Mehrzad", "ForeName": "Jamshid", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran."}], "LastName": "Mirzavi", "ForeName": "Farshad", "Initials": "F"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Biofactors", "NlmUniqueID": "8807441", "ISSNLinking": "0951-6433"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "urolithin B"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "EC 3.4.24.24", "NameOfSubstance": "Matrix Metalloproteinase 2"}, {"RegistryNumber": "EC 3.4.24.35", "NameOfSubstance": "Matrix Metalloproteinase 9"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Glioblastoma"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["genetics"], "DescriptorName": "Matrix Metalloproteinase 2"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Matrix Metalloproteinase 9"}, {"QualifierName": ["drug therapy", "genetics", "metabolism"], "DescriptorName": "Brain Neoplasms"}, {"QualifierName": [], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": [], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Movement"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Donahue MJ, Blakeley JO, Zhou J, Pomper MG, Laterra J, Van Zijl PC. Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magn Reson Med. 2008;59:336-44."}, {"Citation": "Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS. Breast cancer metastasis to the central nervous system. Am J Pathol. 2005;167:913-20."}, {"Citation": "Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. J Neurooncol. 2012;107:359-64."}, {"Citation": "Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and Chemopreventive agents. Med Princ Pract. 2016;25(Suppl 2):41-59."}, {"Citation": "Huang Y, Hou Y, Qu P, Cai Y. Editorial: combating cancer with natural products: what would non-coding RNAs bring? Front Oncol. 2021;11:747586."}, {"Citation": "Gim\u00e9nez-Bastida JA, \u00c1vila-G\u00e1lvez M\u00c1, Esp\u00edn JC, Gonz\u00e1lez-Sarr\u00edas A. Evidence for health properties of pomegranate juices and extracts beyond nutrition: a critical systematic review of human studies. Trends Food Sci Technol. 2021;114:410-23."}, {"Citation": "Esp\u00edn JC, Larrosa M, Garc\u00eda-Conesa MT, Tom\u00e1s-Barber\u00e1n F. Biological significance of urolithins, the gut microbial ellagic acid-derived metabolites: the evidence so far. Evid Based Complement Alternat Med. 2013;2013:270418."}, {"Citation": "Hartman RE, Shah A, Fagan AM, Schwetye KE, Parsadanian M, Schulman RN, et al. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol Dis. 2006;24:506-15."}, {"Citation": "Essa MM, Subash S, Akbar M, Al-Adawi S, Guillemin GJ. Long-term dietary supplementation of pomegranates, figs and dates alleviate neuroinflammation in a transgenic mouse model of Alzheimer's disease. PLoS One. 2015;10:e0120964."}, {"Citation": "Gasperotti M, Passamonti S, Tramer F, Masuero D, Guella G, Mattivi F, et al. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem Nerosci. 2015;6:1341-52."}, {"Citation": "Kujawska M, Jourdes M, Kurpik M, Szulc M, Szaefer H, Chmielarz P, et al. Neuroprotective effects of pomegranate juice against Parkinson's disease and presence of Ellagitannins-derived metabolite-Urolithin A-in the brain. Int J Mol Sci. 2020;21:202."}, {"Citation": "Garc\u00eda-Villalba R, Gim\u00e9nez-Bastida JA, Cort\u00e9s-Mart\u00edn A, \u00c1vila-G\u00e1lvez M\u00c1, Tom\u00e1s-Barber\u00e1n FA, Selma MV, et al. Urolithins: a comprehensive update on their metabolism, bioactivity, and associated gut microbiota. Mol Nutr Food Res. 2022;e2101019."}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A, N\u00fa\u00f1ez-S\u00e1nchez M\u00c1, Tom\u00e1s-Barber\u00e1n FA, Esp\u00edn JC. Neuroprotective effects of bioavailable polyphenol-derived metabolites against oxidative stress-induced cytotoxicity in human Neuroblastoma SH-SY5Y cells. J Agric Food Chem. 2017;65:752-8."}, {"Citation": "DaSilva NA, Nahar PP, Ma H, Eid A, Wei Z, Meschwitz S, et al. Pomegranate ellagitannin-gut microbial-derived metabolites, urolithins, inhibit neuroinflammation in vitro. Nutr Neurosci. 2019;22:185-95."}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A, Esp\u00edn JC, Tom\u00e1s-Barber\u00e1n FA, Garc\u00eda-Conesa MT. Gene expression, cell cycle arrest and MAPK signalling regulation in Caco-2 cells exposed to ellagic acid and its metabolites, urolithins. Mol Nutr Food Res. 2009;53:686-98."}, {"Citation": "Kasimsetty SG, Bialonska D, Reddy MK, Thornton C, Willett KL, Ferreira D. Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J Agric Food Chem. 2009;57:10636-44."}, {"Citation": "Adams LS, Zhang Y, Seeram NP, Heber D, Chen S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res (Phila). 2010;3:108-13."}, {"Citation": "Qiu Z, Zhou B, Jin L, Yu H, Liu L, Liu Y, et al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells. Food Chem Toxicol. 2013;59:428-37."}, {"Citation": "Pr\u00e4bst K, Engelhardt H, Ringgeler S, H\u00fcbner H. Basic colorimetric proliferation assays: MTT, WST, and Resazurin. Methods Mol Biol. 2017;1601:1-17."}, {"Citation": "Jalili-Nik M, Abbasinezhad-Moud F, Sahab-Negah S, Maghrouni A, Etezad Razavi M, Khaleghi Ghadiri M, et al. Antitumor effects of 5-Aminolevulinic acid on human malignant glioblastoma cells. Int J Mol Sci. 2021;22:5596."}, {"Citation": "Jalili-Nik M, Sadeghi MM, Mohtashami E, Mollazadeh H, Afshari AR, Sahebkar A. Zerumbone promotes cytotoxicity in human malignant glioblastoma cells through reactive oxygen species (ROS) generation. Oxid Med Cell Longev. 2020;2020:3237983-9."}, {"Citation": "Lyublinskaya OG, Ivanova JS, Pugovkina NA, Kozhukharova IV, Kovaleva ZV, Shatrova AN, et al. Redox environment in stem and differentiated cells: a quantitative approach. Redox Biol. 2017;12:758-69."}, {"Citation": "Sahab-Negah S, Ariakia F, Jalili-Nik M, Afshari AR, Salehi S, Samini F, et al. Curcumin loaded in Niosomal nanoparticles improved the anti-tumor effects of free curcumin on glioblastoma stem-like cells: an In vitro study. Mol Neurobiol. 2020;57:3391-411."}, {"Citation": "Jalili-Nik M, Afshari AR, Sabri H, Bibak B, Mollazadeh H, Sahebkar A. Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro. Biofactors. 2021;47:729-39."}, {"Citation": "Afshari AR, Jalili-Nik M, Soukhtanloo M, Ghorbani A, Sadeghnia HR, Mollazadeh H, et al. Auraptene-induced cytotoxicity mechanisms in human malignant glioblastoma (U87) cells: role of reactive oxygen species (ROS). EXCLI J. 2019;18:576-90."}, {"Citation": "Poonaki E, Ariakia F, Jalili-Nik M, Shafiee Ardestani M, Tondro G, Samini F, et al. Targeting BMI-1 with PLGA-PEG nanoparticle-containing PTC209 modulates the behavior of human glioblastoma stem cells and cancer cells. Cancer Nanotechnol. 2021;12:5."}, {"Citation": "Zhang L, Wang JN, Tang JM, Kong X, Yang JY, Zheng F, et al. VEGF is essential for the growth and migration of human hepatocellular carcinoma cells. Mol Biol Rep. 2012;39:5085-93."}, {"Citation": "Zhou W, Yu X, Sun S, Zhang X, Yang W, Zhang J, et al. Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence. Biomed Pharmacother. 2019;118:109369."}, {"Citation": "Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381-97."}, {"Citation": "Demain AL, Vaishnav P. Natural products for cancer chemotherapy. J Microbial Biotechnol. 2011;4:687-99."}, {"Citation": "Al-Harbi SA, Abdulrahman AO, Zamzami MA, Khan MI. Urolithins: the gut based polyphenol metabolites of Ellagitannins in cancer prevention, a review. Front Nutr. 2021;8:647582."}, {"Citation": "Lv MY, Shi CJ, Pan FF, Shao J, Feng L, Chen G, et al. Urolithin B suppresses tumor growth in hepatocellular carcinoma through inducing the inactivation of Wnt/\u03b2-catenin signaling. J Cell Biochem. 2019;120:17273-82."}, {"Citation": "Kasimsetty SG, Bialonska D, Reddy MK, Ma G, Khan SI, Ferreira D. Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins. J Agric Food Chem. 2010;58:2180-7."}, {"Citation": "Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010;44:479-96."}, {"Citation": "El-Wetidy MS, Ahmad R, Rady I, Helal H, Rady MI, Vaali-Mohammed MA, et al. Urolithin a induces cell cycle arrest and apoptosis by inhibiting Bcl-2, increasing p53-p21 proteins and reactive oxygen species production in colorectal cancer cells. Cell Stress Chaperones. 2021;26:473-93."}, {"Citation": "Gottlieb E, Vander Heiden MG, Thompson CB. Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol Cell Biol. 2000;20:5680-9."}, {"Citation": "Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med. 2004;25:17-26."}, {"Citation": "Naseri MH, Mahdavi M, Davoodi J, Tackallou SH, Goudarzvand M, Neishabouri SH. Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells. Cancer Cell Int. 2015;15:55."}, {"Citation": "Dejean LM, Martinez-Caballero S, Guo L, Hughes C, Teijido O, Ducret T, et al. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol Biol Cell. 2005;16:2424-32."}, {"Citation": "Zhou B, Wang J, Zheng G, Qiu Z. Methylated urolithin a, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21. Food Chem Toxicol. 2016;97:375-84."}, {"Citation": "Karch J, Molkentin JD. Regulated necrotic cell death. Circ Res. 2015;116:1800-9."}, {"Citation": "Marzo I, Brenner C, Zamzami N, J\u00fcrgensmeier JM, Susin SA, Vieira HL, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (New York, NY). 1998;281:2027-31."}, {"Citation": "Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, et al. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci U S A. 1998;95:1455-9."}, {"Citation": "Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, et al. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020;177:1409-23."}, {"Citation": "Gonz\u00e1lez-Sarr\u00edas A, Tom\u00e9-Carneiro J, Bellesia A, Tom\u00e1s-Barber\u00e1n FA, Esp\u00edn JC. The ellagic acid-derived gut microbiota metabolite, urolithin a, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells. Food Funct. 2015;6:1460-9."}, {"Citation": "Xu J, Yuan C, Wang G, Luo J, Ma H, Xu L, et al. Urolithins attenuate LPS-induced Neuroinflammation in BV2Microglia via MAPK, Akt, and NF-\u03baB signaling pathways. J Agric Food Chem. 2018;66:571-80."}, {"Citation": "Lah TT, Novak M, Breznik B. Brain malignancies: glioblastoma and brain metastases. Semin Cancer Biol. 2020;60:262-73."}, {"Citation": "Wells A, Grahovac J, Wheeler S, Ma B, Lauffenburger D. Targeting tumor cell motility as a strategy against invasion and metastasis. Trends Pharmacol Sci. 2013;34:283-9."}, {"Citation": "Onishi M, Kurozumi K, Ichikawa T, Date I. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme. Neurol Med Chir. 2013;53:755-63."}, {"Citation": "Alauddin M, Okumura T, Rajaxavier J, Khozooei S, P\u00f6schel S, Takeda S, et al. Gut bacterial metabolite Urolithin a decreases Actin polymerization and migration in cancer cells. Mol Nutr Food Res. 2020;64:e1900390."}, {"Citation": "Gim\u00e9nez-Bastida JA, Larrosa M, Gonz\u00e1lez-Sarr\u00edas A, Tom\u00e1s-Barber\u00e1n F, Esp\u00edn JC, Garc\u00eda-Conesa MT. Intestinal ellagitannin metabolites ameliorate cytokine-induced inflammation and associated molecular markers in human colon fibroblasts. J Agric Food Chem. 2012;60:8866-76."}, {"Citation": "Devy L, Dransfield DT. New strategies for the next generation of matrix-metalloproteinase inhibitors: selectively targeting membrane-anchored MMPs with therapeutic antibodies. Biochem Res Int. 2011;2011:191670."}, {"Citation": "Zhao W, Shi F, Guo Z, Zhao J, Song X, Yang H. Metabolite of ellagitannins, urolithin a induces autophagy and inhibits metastasis in human sw620 colorectal cancer cells. Mol Carcinog. 2018;57:193-200."}, {"Citation": "Cerd\u00e1 B, Esp\u00edn JC, Parra S, Mart\u00ednez P, Tom\u00e1s-Barber\u00e1n FA. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr. 2004;43:205-20."}], "ReferenceList": [], "Title": "REFERENCES"}], "History": [{"Year": "2022", "Month": "8", "Day": "26"}, {"Year": "2022", "Month": "10", "Day": "5"}, {"Year": "2023", "Month": "4", "Day": "14", "Hour": "6", "Minute": "42"}, {"Year": "2022", "Month": "11", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "10", "Day": "31", "Hour": "1", "Minute": "43"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36310375", "10.1002/biof.1915"]}}], "PubmedBookArticle": []}